Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Specific RNA patterns are linked to alopecia areata.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Higher levels of certain plasma protein ratios may increase the risk of alopecia areata.

The CRABP I gene in cashmere goats is highly conserved but has unique features at specific amino sites.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

The RNA AL136131.3 slows down hair growth and speeds up hair loss by affecting sugar breakdown in hair follicles.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

Key genes and RNA networks regulate hair growth and follicle density in Rex rabbits.

A specific DNA pattern in Malassezia restricta may be linked to hair loss in men.

PRP treatment helps hair growth and rebalances scalp bacteria in androgenetic alopecia patients.

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

A new method for treating male pattern baldness in men with a low chance of improvement was discussed.

Belatacept may be a promising treatment for alopecia areata.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The Rigenera method improved hair thickness and reduced hair loss in patients.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Certain blood markers, especially MLR, can help diagnose alopecia areata.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.